SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-16-004265
Filing Date
2016-02-22
Accepted
2016-02-22 09:27:38
Documents
3
Period of Report
2016-02-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K s102677_8k.htm 8-K 15412
2 EXHIBIT 99.1 s102677_ex99-1.htm EX-99.1 16803
3 GRAPHIC tex99-1pg1.jpg GRAPHIC 14814
  Complete submission text file 0001615774-16-004265.txt   54072
Mailing Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD, SUITE #500 ONE PENN CENTER PHILADELPHIA PA 19103 215-988-0080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-27072 | Film No.: 161443789
SIC: 2836 Biological Products, (No Diagnostic Substances)